List of works by Ivan Matouš-Malbohan

Antiphospholipid Antibodies in Patients with Lupus Nephritis

scientific article published on 01 September 2003

Experimental allergic encephalomyelitis (EAE)-changes in structure and proliferation in rat lymph nodes after sensitization with guinea-pig and bovine basic myelin protein

scientific article

Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant

scientific article

Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?

scientific article published in October 2009

Glycoxidation and inflammation in chronic haemodialysis patients

scientific article published in December 2003

Increased levels of pregnancy-associated plasma protein A are associated with mortality in hemodialysis patients: preliminary results

scientific article published on 27 May 2004

Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment.

scientific article

Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients

Influence of heparin and protamine on enlargement of the draining lymph node during induction of EAE.

scientific article

Intravenous iron gluconate administration increases circulating PAPP-A in hemodialysis patients

scientific article published in January 2005

Oxidative stress and inflammation in pregnancy

scientific article published on 01 January 2006

Oxidative stress, metabolism of ethanol and alcohol-related diseases

article

PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.

scientific article published in January 2003

Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities

scientific article

T04-P-022 Advanced glycation and oxidation products in patients with atherosclerosis